1. Home
2. ICD-10 Codes
3. Chapter - S00-T88
4. Section - T80-T88
5. Category - T80
6. T80.82

T80.82 - Complication of immune effector cellular therapy

• Applicable to Complication of immune effector cellular therapy
• The 2025 edition of ICD10-CM T80.82 became effective on October 1, 2024.
• This is the American ICD10-CM version of T80.82 - other international versions of ICD10 T80.82 may differ.
• T80.82 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

Code Additional Code:

• code to identify the specific complication, such as:
• cytokine release syndrome (D89.83-)
• immune effector cell-associated neurotoxicity syndrome (G92.0-)

• Complication of chimeric antigen receptor (CAR-T) cell therapy
• Complication of IEC therapy

Type 2 Excludes

• complication of bone marrow transplant (T86.0)
• complication of stem cell transplant (T86.5)

The following codes above T80.82 contain annotation back-references that may be applicable to T80.82:

• Chapter: S00-T88 - Injury, poisoning and certain other consequences of external causes
• Section: T80-T88 - Complications of surgical and medical care, not elsewhere classified
• Category: T80 - Complications following infusion, transfusion and therapeutic injection

Browse other similar CM codes:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.